U.S. markets closed
  • S&P Futures

    3,598.50
    -3.00 (-0.08%)
     
  • Dow Futures

    28,822.00
    +21.00 (+0.07%)
     
  • Nasdaq Futures

    10,997.50
    -38.00 (-0.34%)
     
  • Russell 2000 Futures

    1,670.60
    +0.80 (+0.05%)
     
  • Crude Oil

    82.07
    +2.58 (+3.25%)
     
  • Gold

    1,672.00
    0.00 (0.00%)
     
  • Silver

    19.13
    +0.09 (+0.48%)
     
  • EUR/USD

    0.9793
    -0.0008 (-0.08%)
     
  • 10-Yr Bond

    3.8040
    +0.0570 (+1.52%)
     
  • Vix

    31.62
    -0.22 (-0.69%)
     
  • GBP/USD

    1.1132
    -0.0034 (-0.30%)
     
  • USD/JPY

    144.8410
    +0.1120 (+0.08%)
     
  • BTC-USD

    19,062.54
    -247.22 (-1.28%)
     
  • CMC Crypto 200

    443.49
    +0.06 (+0.01%)
     
  • FTSE 100

    6,893.81
    +12.22 (+0.18%)
     
  • Nikkei 225

    25,937.21
    -484.89 (-1.84%)
     

The Oncology Institute Announces Second Quarter 2022 Earnings Release Date and Conference Call

·1 min read
Toi Management, LLC
Toi Management, LLC

CERRITOS, Calif., July 19, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI) today announced that the company will release its second quarter results after the market close on Tuesday August 9, 2022, to be followed by a conference call the same day 5:00 p.m. (Eastern Time).

The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13731004. The replay will be available until August 16, 2022.

Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company’s website at https://investors.theoncologyinstitute.com/.

About The Oncology Institute

Founded in 2007, The Oncology Institute of Hope and Innovation (TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of more than 1.5 million patients including clinical trials, stem cell transplants, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 80+ employed clinicians and more than 600 teammates in 50+ clinic locations and growing, TOI is changing oncology for the better.

Contacts
Media
The Oncology Institute
Julie Korinke
juliekorinke@theoncologyinstitute.com
(562) 735-3226 x 88806

Revive
Michael Petrone
mpetrone@reviveagency.com
(615) 760-4542

Investors
Solebury Trout
Maria Lycouris
investors@theoncologyinstitute.com